Inogen Historical Cash Flow
| INGN Stock | USD 9.63 0.03 0.31% |
Analysis of Inogen cash flow over time is an excellent tool to project Inogen Inc future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Working Capital of 15 M or Begin Period Cash Flow of 120.7 M as it is a great indicator of Inogen ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Inogen Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Inogen Inc is a good buy for the upcoming year.
Inogen |
About Inogen Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Inogen balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Inogen's non-liquid assets can be easily converted into cash.
Inogen Cash Flow Chart
Add Fundamental
Change To Inventory
The increase or decrease in the amount of inventory a company has over a certain period.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Depreciation
Depreciation indicates how much of Inogen Inc value has been used up. For tax purposes Inogen can deduct the cost of the tangible assets it purchases as business expenses. However, Inogen Inc must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Capital Expenditures
Capital Expenditures are funds used by Inogen Inc to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Inogen operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Inogen's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Inogen Inc current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. At this time, Inogen's Cash Flows Other Operating is very stable compared to the past year. As of the 29th of November 2024, Change To Operating Activities is likely to grow to about 8.4 M, though Change In Cash is likely to grow to (58.4 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Other Non Cash Items | 3.0M | 55.2M | 59.6M | 62.6M | Depreciation | 21.6M | 23.5M | 18.2M | 14.9M |
Inogen cash flow statement Correlations
Click cells to compare fundamentals
Inogen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Inogen cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (10.3M) | 7.6M | (10.8M) | (5.6M) | 7.9M | 8.3M | |
| Change In Cash | 1.4M | 13.9M | 23.6M | (48.5M) | (61.5M) | (58.4M) | |
| Stock Based Compensation | 9.1M | 8.2M | 10.9M | 12.3M | 7.4M | 7.0M | |
| Free Cash Flow | 34.1M | 19.4M | (434K) | (58.8M) | (30.2M) | (28.7M) | |
| Change In Working Capital | (27.9M) | (31K) | (20.1M) | (44.7M) | 14.3M | 15.0M | |
| Begin Period Cash Flow | 196.6M | 198.0M | 212.0M | 235.5M | 187.0M | 120.7M | |
| Other Cashflows From Financing Activities | (928K) | 2.1M | 15M | 380K | 960K | 912K | |
| Depreciation | 13.8M | 18.6M | 21.6M | 23.5M | 18.2M | 14.9M | |
| Other Non Cash Items | 21.7M | 16.2M | 3.0M | 55.2M | 59.6M | 62.6M | |
| Capital Expenditures | 6.5M | 17.6M | 24.1M | 21.2M | 27.0M | 16.6M | |
| Total Cash From Operating Activities | 40.6M | 37.0M | 23.6M | (37.5M) | (3.2M) | (3.1M) | |
| Change To Account Receivables | (16.7M) | (8.2M) | (6.1M) | (51.3M) | 11.1M | 11.7M | |
| Net Income | 21.0M | (5.8M) | (6.3M) | (83.8M) | (102.4M) | (97.3M) | |
| Total Cash From Financing Activities | 4.9M | 2.1M | 15M | 380K | 960K | 912K | |
| End Period Cash Flow | 198.0M | 212.0M | 235.5M | 187.0M | 125.5M | 130.8M | |
| Change To Netincome | 15.9M | 12.9M | 15.8M | 51.3M | 59.0M | 62.0M | |
| Change To Liabilities | (2.4M) | (4.6M) | 2.6M | 571K | 513.9K | 488.2K | |
| Sale Purchase Of Stock | (928K) | (350K) | (647K) | (1.4M) | (518K) | (492.1K) | |
| Investments | 32.7M | (8.2M) | 9.3M | (10.9M) | (70.4M) | (66.9M) | |
| Change Receivables | (16.7M) | (8.2M) | (6.1M) | (51.3M) | (46.2M) | (43.9M) | |
| Total Cashflows From Investing Activities | (44.1M) | (25.6M) | (14.6M) | (10.9M) | (12.5M) | (13.1M) | |
| Cash And Cash Equivalents Changes | 1.5M | 13.4M | 24.0M | (48.0M) | (43.2M) | (41.1M) | |
| Cash Flows Other Operating | 19.3M | 16.5M | 6.8M | 27.8M | 31.9M | 33.5M | |
| Change To Operating Activities | (6.9M) | 5.3M | 2.1M | 7.0M | 8.0M | 8.4M | |
| Other Cashflows From Investing Activities | (73.6M) | (13.0M) | (18.4M) | (17.6M) | (15.8M) | (16.6M) |
Pair Trading with Inogen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inogen will appreciate offsetting losses from the drop in the long position's value.Moving together with Inogen Stock
Moving against Inogen Stock
| 0.59 | ELMD | Electromed | PairCorr |
| 0.49 | DRIO | DarioHealth Corp | PairCorr |
| 0.44 | MD | Mednax Inc | PairCorr |
| 0.35 | DOCS | Doximity Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Inogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inogen Inc to buy it.
The correlation of Inogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.873 | Earnings Share (2.25) | Revenue Per Share 14.095 | Quarterly Revenue Growth 0.058 | Return On Assets (0.1) |
The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.